1-3 of 3
Joseph Rajendran, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A Phase II Trial of Myeloablative I-131-Tositumomab, Etoposide and Cyclophosphamide Followed by Autologous Transplantation for B-Cell Non-Hodgkin's Lymphoma

Ajay K. Gopal, MD, Ted A. Gooley, PhD, Joseph Rajendran, MD, John M. Pagel, MD, PhD, Darrell R. Fisher, PhD, David G. Maloney, MD, PhD, Frederick R. Appelbaum, MD, Andrew Shields, MD, Damian J. Green, MD, Oliver W. Press, MD, PhD
Journal: Blood
Blood (2012) 120 (21): 811.
https://doi.org/10.1182/blood.V120.21.811.811
Published: 2012
Journal Articles

A Phase I Study of Myeloablative I-131-Anti CD-20 (Tositumomab) Radioimmunotherapy with Escalating Doses of Fludarabine Followed by Autologous Hematopoietic Stem Cell Transplantation (ASCT) for Adults ≥ 60 Years of Age with High-Risk or Relapsed/Refractory B-Cell Lymphoma

Ajay K. Gopal, MD, Ted Gooley, Joseph Rajendran, MD, John M. Pagel, MD, PhD, Darrell R. Fisher, PhD, David G. Maloney, MD, PhD, Frederick R. Appelbaum, MD, Andrew Shields, MD, Oliver W. Press, MD, PhD
Journal: Blood
Blood (2011) 118 (21): 663.
https://doi.org/10.1182/blood.V118.21.663.663
Published: 2011
Journal Articles

Y-90-Ibritumomab Tiuxetan, Fluadarabine and TBI Based Non-Myeloablative Allogeneic Transplant Conditioning for High-Risk B-Cell Lymphoma

Ajay K Gopal, MD, Kathrine Guthrie, PhD, Joseph Rajendran, MD, John M. Pagel, MD, PhD, George Oliviera, MD, David G Maloney, MD., PhD, Rainer F. Storb, MD, Oliver W. Press, MD, PhD
Journal: Blood
Blood (2010) 116 (21): 33.
https://doi.org/10.1182/blood.V116.21.33.33
Published: 2010